Clinical Features and Pathogenic Mechanisms of Gastrointestinal Injury in COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the global coronavirus disease 2019 (COVID-19) outbreak. Along with the respiratory tract, the gastrointestinal (GI) tract is one of the main extra-pulmonary targets of SARS-CoV-2 with respect to symptom occurrence and is a potential route for virus transmission, most likely due to the presence of angiotensin-converting enzyme 2. Therefore, understanding the mechanisms of GI injury is crucial for a harmonized therapeutic strategy against COVID-19. This review summarizes the current evidence for the clinical features of and possible pathogenic mechanisms leading to GI injury in COVID-19.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
---|---|
Enthalten in: |
Journal of clinical medicine - 9(2020), 11 vom: 11. Nov. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Mitsuyama, Keiichi [VerfasserIn] |
---|
Links: |
---|
Themen: |
ACE2 |
---|
Anmerkungen: |
Date Revised 30.03.2024 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3390/jcm9113630 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM31754750X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM31754750X | ||
003 | DE-627 | ||
005 | 20240330233708.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/jcm9113630 |2 doi | |
028 | 5 | 2 | |a pubmed24n1356.xml |
035 | |a (DE-627)NLM31754750X | ||
035 | |a (NLM)33187280 | ||
035 | |a (PII)E3630 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Mitsuyama, Keiichi |e verfasserin |4 aut | |
245 | 1 | 0 | |a Clinical Features and Pathogenic Mechanisms of Gastrointestinal Injury in COVID-19 |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 30.03.2024 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the global coronavirus disease 2019 (COVID-19) outbreak. Along with the respiratory tract, the gastrointestinal (GI) tract is one of the main extra-pulmonary targets of SARS-CoV-2 with respect to symptom occurrence and is a potential route for virus transmission, most likely due to the presence of angiotensin-converting enzyme 2. Therefore, understanding the mechanisms of GI injury is crucial for a harmonized therapeutic strategy against COVID-19. This review summarizes the current evidence for the clinical features of and possible pathogenic mechanisms leading to GI injury in COVID-19 | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a ACE2 | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a TMPRSS2 | |
650 | 4 | |a gastrointestinal tract | |
650 | 4 | |a gut microbiota | |
650 | 4 | |a intestine | |
650 | 4 | |a renin-angiotensin-aldosterone system | |
650 | 4 | |a thrombosis | |
650 | 4 | |a tryptophan | |
700 | 1 | |a Tsuruta, Kozo |e verfasserin |4 aut | |
700 | 1 | |a Takedatsu, Hidetoshi |e verfasserin |4 aut | |
700 | 1 | |a Yoshioka, Shinichiro |e verfasserin |4 aut | |
700 | 1 | |a Morita, Masaru |e verfasserin |4 aut | |
700 | 1 | |a Niwa, Mikio |e verfasserin |4 aut | |
700 | 1 | |a Matsumoto, Satoshi |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of clinical medicine |d 2012 |g 9(2020), 11 vom: 11. Nov. |w (DE-627)NLM230666310 |x 2077-0383 |7 nnns |
773 | 1 | 8 | |g volume:9 |g year:2020 |g number:11 |g day:11 |g month:11 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/jcm9113630 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 9 |j 2020 |e 11 |b 11 |c 11 |